# Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6

> **NCT03858894** · PHASE2 · COMPLETED · sponsor: **Santen Inc.** · enrollment: 98 (actual)

## Conditions studied

- Primary Open-angle Glaucoma and Ocular Hypertension

## Interventions

- **DRUG:** DE-117 Ophthalmic Solution QD
- **DRUG:** DE-117 Ophthalmic Solution BID

## Key facts

- **NCT ID:** NCT03858894
- **Lead sponsor:** Santen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-28
- **Primary completion:** 2019-06-20
- **Final completion:** 2019-06-20
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2020-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03858894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03858894, "Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03858894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*